Detalhe da pesquisa
1.
Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for EGFR mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01).
Jpn J Clin Oncol
; 54(3): 319-328, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997468
2.
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.
Cancer Chemother Pharmacol
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584202
3.
A novel anti-MUC1 antibody against the MUC1 cytoplasmic tail domain: use in sensitive identification of poorly differentiated cells in adenocarcinoma of the stomach.
Gastric Cancer
; 15(4): 370-81, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237656
4.
Osimertinib and Bevacizumab Cotreatment for Untreated EGFR-Mutated NSCLC With Malignant Pleural or Pericardial Effusion (SPIRAL II): A Single-Arm, Open-Label, Phase 2 Clinical Trial.
JTO Clin Res Rep
; 3(12): 100424, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36438852
5.
Multidisciplinary Lung Cancer Tumor Board Connecting Eight General Hospitals in Japan via a High-Security Communication Line.
JCO Clin Cancer Inform
; 3: 1-7, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860865
6.
MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
PLoS One
; 7(11): e49251, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23152882
7.
Degradation of Aflatoxins by Food Additives.
J Food Prot
; 57(1): 42-47, 1994 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31113025